Clinical Trial

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-23; most recent amendment 2026-02-04.
Status change: Enrolling by Invitation → Recruiting 2024-04-08
Trial Details
NCT Number NCT06100991
Lead Sponsor CorEvitas
Conditions Generalized Pustular Psoriasis
Enrollment 200 participants
Start Date 2023-09-19
Primary Completion 2099-12 (estimated)
Study Completion 2099-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-09